Literature DB >> 16710600

Hepatocellular focal nodular hyperplasia after danazol treatment for hereditary angio-oedema.

Per Helsing, Erik W Nielsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16710600     DOI： 10.2340/00015555-0057

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  6 in total

1.  Danazol-Induced Hepatocellular Carcinoma in a Patient with Hereditary Angioedema.

Authors:  Muhammed Hameed Thoufeeq; Javaid Ishtiaq; Mohamed Abuzakouk
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  The effect of long-term danazol prophylaxis on liver function in hereditary angioedema-a longitudinal study.

Authors:  Henriette Farkas; Ibolya Czaller; Dorottya Csuka; Anikó Vas; Szilvia Valentin; Lilian Varga; Gábor Széplaki; László Jakab; George Füst; Zoltán Prohászka; George Harmat; Beata Visy; István Karádi
Journal:  Eur J Clin Pharmacol       Date:  2009-12-19       Impact factor: 2.953

3.  Hepatocellular carcinoma in a noncirrhotic liver after long-term use of danazol for hereditary angioedema.

Authors:  Soraya Rahal; Marine Gilabert; Pauline Ries; Sandrine Oziel-Taieb; Slimane Dermeche; Jean-Luc Raoul
Journal:  Case Rep Oncol       Date:  2014-12-09

4.  Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema.

Authors:  Timothy Craig; Ralph Shapiro; Arthur Vegh; James W Baker; Jonathan A Bernstein; Paula Busse; Markus Magerl; Inmaculada Martinez-Saguer; Marc A Riedl; William Lumry; Debora Williams-Herman; Jonathan Edelman; Henrike Feuersenger; Thomas Machnig; Mikhail Rojavin
Journal:  Allergy Rhinol (Providence)       Date:  2017-03-01

5.  Outcomes of long term treatments of type I hereditary angioedema in a Turkish family.

Authors:  Gulsen Akoglu; Belgin Kesim; Gokhan Yildiz; Ahmet Metin
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

6.  Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert® (C1-INH) Registry.

Authors:  Anette Bygum; Inmaculada Martinez-Saguer; Murat Bas; Jeffrey Rosch; Jonathan Edelman; Mikhail Rojavin; Debora Williams-Herman
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.